Genes, compositions, kits, and methods for identification,...

Chemistry: analytical and immunological testing – Cancer

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S006120, C435S007100, C435S007230, C530S350000, C530S387700, C536S023500, C536S024300

Reexamination Certificate

active

07846737

ABSTRACT:
The invention relates to newly discovered nucleic acid molecules and proteins associated with cervical cancer including pre-malignant conditions such as dysplasia. Compositions, kits, and methods for detecting, characterizing, preventing, and treating human cervical cancers are provided.

REFERENCES:
patent: 2002/0086354 (2002-07-01), Holtzman et al.
patent: 2002/0169284 (2002-11-01), Ashkenazi et al.
patent: 2002/0177553 (2002-11-01), Ashkenazi et al.
patent: 2002/0192706 (2002-12-01), Ashkenazi et al.
patent: 2003/0008352 (2003-01-01), Baker et al.
patent: 2003/0008353 (2003-01-01), Baker et al.
patent: 2003/0013153 (2003-01-01), Baker et al.
patent: 2003/0049738 (2003-03-01), Baker et al.
patent: 2003/0087270 (2003-05-01), Schlegel et al.
patent: 2003/0175754 (2003-09-01), Murry et al.
patent: 2004/0023288 (2004-02-01), Ridder et al.
patent: 2004/0219579 (2004-11-01), Aziz et al.
patent: 2005/0037010 (2005-02-01), Monahan et al.
patent: 2005/0260566 (2005-11-01), Fischer et al.
patent: 2007/0172830 (2007-07-01), Ruben et al.
patent: 1167387 (2002-01-01), None
patent: 2000-32984 (2000-02-01), None
patent: WO-99/07850 (1999-02-01), None
patent: WO-99/07893 (1999-02-01), None
patent: WO-99/35158 (1999-07-01), None
patent: WO-99/46281 (1999-09-01), None
patent: WO-99/58660 (1999-11-01), None
patent: WO-00/53756 (2000-09-01), None
patent: WO-01/42451 (2001-06-01), None
patent: WO-01/54708 (2001-08-01), None
patent: WO-01/68848 (2001-09-01), None
patent: WO-01/87917 (2001-11-01), None
patent: WO-02/057414 (2002-07-01), None
patent: WO-02/068649 (2002-09-01), None
Li (J. Cell Biol. Feb. 21, 2000; 148 (4): 791-800).
Hadj-Rabia et al. (Gastroenterology. Nov. 2004; 127 (5): 1386-1390).
Roessler et al. (Mol. Cell. Prot. 2006; 5 (11): 2092-2101).
Roessler et al. (Clin. Can. Res. 2005; 11 (18): 6550-6557).
Zolg et al. (Mol. Cell. Prot. 2004; 3 (4): 345-354).
Rae et al. (Int. J. Cancer. 2000; 88: 726-732).
Cheng et al. (Br. J. Cancer. 2002; 86: 274-281).
Ward (Developmental Oncology 1985; 21: 91-106).
Critchfield (Disease Markers. 1999; 15: 108-111).
Sidransky (Science. 1997; 278: 1054-1058).
Tockman et al (Cancer Res. 1992; 52: 2711s-2718s).
Swisshelm et al. (Gene. 1999; 226: 285-295).
Timmons et al. (Endocrinol. 2007; 148 (3): 1278-1287).
Morita et al. (Br. J. Dermatol. 2004; 151: 328-334).
Grone et al. (Int. J. Colorectal Dis. 2007; 22: 651-659).
Leotlela et al. (Oncogene. 2007; 26: 3846-3856).
Chen et al. (Molecular & Cellular Proteomics. 2002; 1: 304-313).
Vasquez-Ortiz et al. (Arch. Med. Res. Sep.-Oct. 2005; 36 (5): 448-458).
Lee et al. (Gynecol. Oncol. Apr. 2005; 97 (1): 53-59).
Sobel et al. (Hum. Pathol. Feb. 2005; 36 (2): 162-169).
GenBank AC NP—066924, Zimmerli, S.C. et al., “Human epidermal langerhans cells express the tight junction protein claudin-1 and are present in human genetic claudin-1 deficiency (NISCH syndrome),”Exp. Dermatol., vol. 17(1):20-23 (2008) Feb. 17, 2008.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Genes, compositions, kits, and methods for identification,... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Genes, compositions, kits, and methods for identification,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Genes, compositions, kits, and methods for identification,... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4179473

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.